These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23235826)

  • 1. Neurodevelopmental disorders: Signalling pathways of fragile X syndrome.
    Jayaseelan S; Tenenbaum SA
    Nature; 2012 Dec; 492(7429):359-60. PubMed ID: 23235826
    [No Abstract]   [Full Text] [Related]  

  • 2. FMRP targets distinct mRNA sequence elements to regulate protein expression.
    Ascano M; Mukherjee N; Bandaru P; Miller JB; Nusbaum JD; Corcoran DL; Langlois C; Munschauer M; Dewell S; Hafner M; Williams Z; Ohler U; Tuschl T
    Nature; 2012 Dec; 492(7429):382-6. PubMed ID: 23235829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding fragile X syndrome and related disorders.
    Rooms L; Kooy RF
    Curr Opin Pediatr; 2011 Dec; 23(6):601-6. PubMed ID: 22001764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules.
    El Fatimy R; Davidovic L; Tremblay S; Jaglin X; Dury A; Robert C; De Koninck P; Khandjian EW
    PLoS Genet; 2016 Jul; 12(7):e1006192. PubMed ID: 27462983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of
    Kumari D; Usdin K
    Expert Rev Mol Diagn; 2020 Apr; 20(4):363-365. PubMed ID: 32067539
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of FMRP-associated mRNAs using yeast three-hybrid system.
    Zou K; Liu J; Zhu N; Lin J; Liang Q; Brown WT; Shen Y; Zhong N
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):769-77. PubMed ID: 18163424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP.
    Majumder P; Chu JF; Chatterjee B; Swamy KB; Shen CJ
    Acta Neuropathol; 2016 Nov; 132(5):721-738. PubMed ID: 27518042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein.
    Duan R; Jin P
    Methods Mol Biol; 2006; 342():267-76. PubMed ID: 16957381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription, translation and fragile X syndrome.
    Garber K; Smith KT; Reines D; Warren ST
    Curr Opin Genet Dev; 2006 Jun; 16(3):270-5. PubMed ID: 16647847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel function for fragile X mental retardation protein in translational activation.
    Bechara EG; Didiot MC; Melko M; Davidovic L; Bensaid M; Martin P; Castets M; Pognonec P; Khandjian EW; Moine H; Bardoni B
    PLoS Biol; 2009 Jan; 7(1):e16. PubMed ID: 19166269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
    Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
    J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
    Niere F; Wilkerson JR; Huber KM
    J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfolding neurodevelopmental disorders: found in translation.
    Ting JT; Feng G
    Nat Med; 2011 Nov; 17(11):1352-3. PubMed ID: 22064412
    [No Abstract]   [Full Text] [Related]  

  • 15. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.
    Boland MJ; Nazor KL; Tran HT; Szücs A; Lynch CL; Paredes R; Tassone F; Sanna PP; Hagerman RJ; Loring JF
    Brain; 2017 Mar; 140(3):582-598. PubMed ID: 28137726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.
    Ronesi JA; Huber KM
    Sci Signal; 2008 Feb; 1(5):pe6. PubMed ID: 18272470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fragile X mental retardation-1 gene with nuclear export signal mutation changes the expression profiling of mouse cerebella immortal neuronal cell.
    Hu L; Chen Y; Evers S; Shen Y
    Proteomics; 2005 Oct; 5(15):3979-90. PubMed ID: 16130171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer.
    Didiot MC; Tian Z; Schaeffer C; Subramanian M; Mandel JL; Moine H
    Nucleic Acids Res; 2008 Sep; 36(15):4902-12. PubMed ID: 18653529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins.
    Chen E; Joseph S
    Biochimie; 2015 Jul; 114():147-54. PubMed ID: 25701550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.